SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-010757 to JRSIS HEALTH CARE Corp (JRSS) (CIK 0001597892) (JRSS)

JRSIS HEALTH CARE Corp (JRSS) (CIK 0001597892)
Date: Sept. 29, 2023 · CIK: 0001597892 · Accession: 0000000000-23-010757

AI Filing Summary & Sentiment

File numbers found in text: 001-36758

Date
September 29, 2023
Author
Not clearly detected
Form
UPLOAD
Company
JRSIS HEALTH CARE Corp (JRSS) (CIK 0001597892)

Letter

United States securities and exchange commission logo September 29, 2023 Zhuowei Zhong President & Chairman of the Board JRSIS HEALTH CARE Corp 3/F Building A , De Run Yuan No. 19 Chang Yi Road , Chang Ming Shui Wu Gui Shan , Zhong Shan City 528458 Re:JRSIS HEALTH CARE Corp Form 10-K for Fiscal Year Ended December 31, 2022 Filed April 17, 2023 Form 10-K/A for Fiscal Year Ended December 31, 2022 Filed July 26, 2023 Response dated July 26, 2023 Response dated August 31, 2023 File No. 001-36758 Dear Zhuowei Zhong: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Robert Brantl

Show Raw Text
United States securities and exchange commission logo
September 29, 2023
Zhuowei Zhong
President & Chairman of the Board
JRSIS HEALTH CARE Corp
3/F Building A , De Run Yuan
No. 19 Chang Yi Road , Chang Ming Shui
Wu Gui Shan , Zhong Shan City 528458
Re:JRSIS HEALTH CARE Corp
Form 10-K for Fiscal Year Ended December 31, 2022
Filed April 17, 2023
Form 10-K/A for Fiscal Year Ended December 31, 2022
Filed July 26, 2023
Response dated July 26, 2023
Response dated August 31, 2023
File No. 001-36758
Dear Zhuowei Zhong:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Robert Brantl